The Mrna Vaccine And Therapeutics Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Mrna Vaccine And Therapeutics Market. With the use of historic data from (period), the Mrna Vaccine And Therapeutics Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.

The global market for Mrna Vaccine And Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in this market include

• Argos Therapeutics
• BioNTech
• CureVac
• eTheRNA
• Ethris
• In-Cell-Art
• Moderna Therapeutics
• Sangamo Therapeutics
• Tiba Biotechnology
• Translate Bio

On the basis of region, the market is divided into:

• North America (U.S. and Canada)
• Latin America (Brazil, Mexico, Argentina, Columbia, and Rest of Latin America)
• Europe (Germany, the U.K., France, Russia, Italy, and Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Southeast Asia, and Rest of Asia Pacific)
• Middle East (Saudi Arabia, UAE, Egypt, and Rest of Middle East)
• Africa (North Africa, Central Africa, and South Africa)

By the product type, the market is primarily segmented into

• Infectious Disease
• Cancer
• Others
• Market segment by Application, split into
• Hospital
• Research Institual

By the End-user Applications, the market is primarily segmented into

• Hospital
• Research Institual

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
  • United States
  • Canada
  • Mexico
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Central & South America
  • Brazil
• Middle East & Africa
  • Turkey
  • GCC Countries
  • Egypt
  • South Africa

Key Highlights of the Report:

• Growth opportunities in the global Mrna Vaccine And Therapeutics Market across major regions during the forecast period.
• Role of emerging markets in the global Mrna Vaccine And Therapeutics Market and the scenario during the 2020-2026.
• Technological and product developments that influence growth of the market.
• New trends and advancements in the global Mrna Vaccine And Therapeutics Market.
• Insight on various product types and their respective market shares in the overall market.

The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

• Raw material suppliers
• Distributors/traders/wholesalers/suppliers
• Regulatory bodies, including government agencies and NGO
• Commercial research & development (R&D) institutions
• Importers and exporters
• Government organizations, research organizations, and consulting firms
• Trade associations and industry bodies
• End-use industries

Available Customizations

At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Infectious Disease 1.4.3 Cancer 1.4.4 Others 1.5 Market by Application 1.5.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Research Institual 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 mRNA Vaccine And Therapeutics Market Perspective (2015-2026) 2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions 2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porters Five Forces Analysis 2.3.5 mRNA Vaccine And Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key mRNA Vaccine And Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top mRNA Vaccine And Therapeutics Players by Market Size 3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2015-2020) 3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global mRNA Vaccine And Therapeutics Market Concentration Ratio 3.2.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2019 3.3 mRNA Vaccine And Therapeutics Key Players Head office and Area Served 3.4 Key Players mRNA Vaccine And Therapeutics Product Solution and Service 3.5 Date of Enter into mRNA Vaccine And Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2021-2026) 5 mRNA Vaccine And Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America mRNA Vaccine And Therapeutics Market Size (2015-2020) 6.2 mRNA Vaccine And Therapeutics Key Players in North America (2019-2020) 6.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 6.4 North America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe mRNA Vaccine And Therapeutics Market Size (2015-2020) 7.2 mRNA Vaccine And Therapeutics Key Players in Europe (2019-2020) 7.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 7.4 Europe mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China mRNA Vaccine And Therapeutics Market Size (2015-2020) 8.2 mRNA Vaccine And Therapeutics Key Players in China (2019-2020) 8.3 China mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 8.4 China mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan mRNA Vaccine And Therapeutics Market Size (2015-2020) 9.2 mRNA Vaccine And Therapeutics Key Players in Japan (2019-2020) 9.3 Japan mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 9.4 Japan mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia mRNA Vaccine And Therapeutics Market Size (2015-2020) 10.2 mRNA Vaccine And Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India mRNA Vaccine And Therapeutics Market Size (2015-2020) 11.2 mRNA Vaccine And Therapeutics Key Players in India (2019-2020) 11.3 India mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 11.4 India mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America mRNA Vaccine And Therapeutics Market Size (2015-2020) 12.2 mRNA Vaccine And Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Argos Therapeutics 13.1.1 Argos Therapeutics Company Details 13.1.2 Argos Therapeutics Business Overview and Its Total Revenue 13.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction 13.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)) 13.1.5 Argos Therapeutics Recent Development 13.2 BioNTech 13.2.1 BioNTech Company Details 13.2.2 BioNTech Business Overview and Its Total Revenue 13.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction 13.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.2.5 BioNTech Recent Development 13.3 CureVac 13.3.1 CureVac Company Details 13.3.2 CureVac Business Overview and Its Total Revenue 13.3.3 CureVac mRNA Vaccine And Therapeutics Introduction 13.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.3.5 CureVac Recent Development 13.4 eTheRNA 13.4.1 eTheRNA Company Details 13.4.2 eTheRNA Business Overview and Its Total Revenue 13.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction 13.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.4.5 eTheRNA Recent Development 13.5 Ethris 13.5.1 Ethris Company Details 13.5.2 Ethris Business Overview and Its Total Revenue 13.5.3 Ethris mRNA Vaccine And Therapeutics Introduction 13.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.5.5 Ethris Recent Development 13.6 In-Cell-Art 13.6.1 In-Cell-Art Company Details 13.6.2 In-Cell-Art Business Overview and Its Total Revenue 13.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction 13.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.6.5 In-Cell-Art Recent Development 13.7 Moderna Therapeutics 13.7.1 Moderna Therapeutics Company Details 13.7.2 Moderna Therapeutics Business Overview and Its Total Revenue 13.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction 13.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.7.5 Moderna Therapeutics Recent Development 13.8 Sangamo Therapeutics 13.8.1 Sangamo Therapeutics Company Details 13.8.2 Sangamo Therapeutics Business Overview and Its Total Revenue 13.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction 13.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.8.5 Sangamo Therapeutics Recent Development 13.9 Tiba Biotechnology 13.9.1 Tiba Biotechnology Company Details 13.9.2 Tiba Biotechnology Business Overview and Its Total Revenue 13.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction 13.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.9.5 Tiba Biotechnology Recent Development 13.10 Translate Bio 13.10.1 Translate Bio Company Details 13.10.2 Translate Bio Business Overview and Its Total Revenue 13.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction 13.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) 13.10.5 Translate Bio Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details List of Table List of Tables Table 1. mRNA Vaccine And Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue Table 3. Ranking of Global Top mRNA Vaccine And Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Infectious Disease Table 6. Key Players of Cancer Table 7. Key Players of Others Table 8. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global mRNA Vaccine And Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global mRNA Vaccine And Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 11. Global mRNA Vaccine And Therapeutics Market Share by Regions (2015-2020) Table 12. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global mRNA Vaccine And Therapeutics Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. mRNA Vaccine And Therapeutics Market Growth Strategy Table 18. Main Points Interviewed from Key mRNA Vaccine And Therapeutics Players Table 19. Global mRNA Vaccine And Therapeutics Revenue by Players (2015-2020) (Million US$) Table 20. Global mRNA Vaccine And Therapeutics Market Share by Players (2015-2020) Table 21. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2019) Table 22. Global mRNA Vaccine And Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players mRNA Vaccine And Therapeutics Product Solution and Service Table 25. Date of Enter into mRNA Vaccine And Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 28. Global mRNA Vaccine And Therapeutics Market Size Share by Type (2015-2020) Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2015-2020) Table 31. Global mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 32. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2021-2026) Table 33. North America Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 34. North America Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 35. North America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 36. North America mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 37. North America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. North America mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 39. Europe Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 40. Europe Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. Europe mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. Europe mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 45. China Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 46. China Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 47. China mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. China mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 49. China mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. China mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 51. Japan Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 52. Japan Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 53. Japan mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Japan mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 55. Japan mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Japan mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 59. Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 61. Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 63. India Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 64. India Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 65. India mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 66. India mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 67. India mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 68. India mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 69. Central & South America Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020) Table 71. Central & South America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America mRNA Vaccine And Therapeutics Market Share by Type (2015-2020) Table 73. Central & South America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America mRNA Vaccine And Therapeutics Market Share by Application (2015-2020) Table 75. Argos Therapeutics Company Details Table 76. Argos Therapeutics Business Overview Table 77. Argos Therapeutics Product Table 78. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 79. Argos Therapeutics Recent Development Table 80. BioNTech Company Details Table 81. BioNTech Business Overview Table 82. BioNTech Product Table 83. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 84. BioNTech Recent Development Table 85. CureVac Company Details Table 86. CureVac Business Overview Table 87. CureVac Product Table 88. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 89. CureVac Recent Development Table 90. eTheRNA Company Details Table 91. eTheRNA Business Overview Table 92. eTheRNA Product Table 93. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 94. eTheRNA Recent Development Table 95. Ethris Company Details Table 96. Ethris Business Overview Table 97. Ethris Product Table 98. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 99. Ethris Recent Development Table 100. In-Cell-Art Company Details Table 101. In-Cell-Art Business Overview Table 102. In-Cell-Art Product Table 103. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 104. In-Cell-Art Recent Development Table 105. Moderna Therapeutics Company Details Table 106. Moderna Therapeutics Business Overview Table 107. Moderna Therapeutics Product Table 108. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 109. Moderna Therapeutics Recent Development Table 110. Sangamo Therapeutics Business Overview Table 111. Sangamo Therapeutics Product Table 112. Sangamo Therapeutics Company Details Table 113. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 114. Sangamo Therapeutics Recent Development Table 115. Tiba Biotechnology Company Details Table 116. Tiba Biotechnology Business Overview Table 117. Tiba Biotechnology Product Table 118. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 119. Tiba Biotechnology Recent Development Table 120. Translate Bio Company Details Table 121. Translate Bio Business Overview Table 122. Translate Bio Product Table 123. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$) Table 124. Translate Bio Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global mRNA Vaccine And Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Infectious Disease Features Figure 3. Cancer Features Figure 4. Others Features Figure 5. Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Research Institual Case Studies Figure 8. mRNA Vaccine And Therapeutics Report Years Considered Figure 9. Global mRNA Vaccine And Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global mRNA Vaccine And Therapeutics Market Share by Regions: 2020 VS 2026 Figure 11. Global mRNA Vaccine And Therapeutics Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Players in 2019 Figure 14. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2019 Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2019 Figure 16. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 25. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 27. CureVac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 29. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 31. Ethris Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 33. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 35. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 37. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 39. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 41. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market: The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Global Antibody Based Therapeutics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Antibody Based Therapeutics Market: The report discusses everything a marketer requires before investing in the global Antibody Based Therapeutics Market during the forecast period 2023-2030. ...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

Global Office-Based Sleep Therapeutics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Office-Based Sleep Therapeutics Market: The report discusses everything a marketer requires before investing in the global Office-Based Sleep Therapeutics Market during the forecast period 202...